Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy
Clinical trial NCT02237196 · COMPLETED
Trial details
- NCT number
- NCT02237196
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-03
- Primary completion
- 2019-03-04
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.